Product Information
SEVELAMER HCL 800 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.7025 per EA under NDC 68462044718. Its NADAC has been published 336 times since Mar 18, 2020.
FDA first approved this application on Feb 8, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462044718
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
PARENTERAL
Effective Date
8/19/2026
Active Ingredients
SEVELAMER HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204724FDA Approved
2/8/2019
TE Code
AB
On Market Since
2/8/2019
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER HCL 800 MG TABLET has been published 336 times since Mar 18, 2020, and over the history we have for it it has declined 84.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7025 per EA |
|---|---|
| All-time high | $5.0305 (Mar 10, 2021) |
| All-time low | $0.7025 (Aug 19, 2026) |
| 52-week high | $1.3679 |
| 52-week low | $0.7025 |
| Median price | $2.3333 |
| Average price | $2.8246 |
| Largest weekly change | -37.7% (May 22, 2024) |
| Weeks tracked | 336 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SEVELAMER HCL 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.7025 per EA (NDC 68462044718), effective Aug 19, 2026.
How has the price of SEVELAMER HCL 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 84.9%. It has been tracked across 336 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?
Since Mar 18, 2020, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.7025 (Aug 19, 2026) to a high of $5.0305 (Mar 10, 2021), with a median of $2.3333 per EA.
Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SEVELAMER HCL 800 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SEVELAMER HCL 800 MG TABLET?
SEVELAMER HCL 800 MG TABLET (NDC 68462044718) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.